Pimecrolimus — brands & medicines in Pakistan
Pakistan mein Pimecrolimus ke 1 brands available hain. Drug class: Calcineurin Inhibitor / Topical Immunomodulator. Neeche se koi bhi brand select karein aur uses, dosage, side effects aur price dekhein.
Quick Answer
Pimecrolimus is a calcineurin inhibitor / topical immunomodulator used in Pakistan for Mild to moderate atopic dermatitis (eczema), Short-term and intermittent long-term treatment of facial eczema, Steroid-sparing therapy in eczema-prone patients. Available as 1 brand. Prescription required. Always confirm dose with a doctor or pharmacist.
What is Pimecrolimus?
Pimecrolimus is a calcineurin inhibitor / topical immunomodulator used in Pakistan for a range of medical conditions. Doctors and pharmacists in Pakistan recognize Pimecrolimus under multiple brand names — currently 1 listed on PakVita (1 cream). The information below is a synthesis from DRAP-registered medicine entries, BNF, and WHO Essential Medicines references.
Common indications
- Mild to moderate atopic dermatitis (eczema)
- Short-term and intermittent long-term treatment of facial eczema
- Steroid-sparing therapy in eczema-prone patients
Indication and dose vary by medical condition, age, weight, and other factors. Always confirm with a qualified doctor or pharmacist before starting.
Typical dosage
Apply a thin layer twice daily to affected skin; use for the minimum necessary duration
This is a general adult guidance pattern based on the manufacturer's label for one of the Pimecrolimus brands listed below. Children, elderly patients, pregnant women, and people with kidney or liver impairment usually need different dosing — confirm with your doctor.
Side effects
Common (usually mild)
- Burning or stinging sensation at application site
- Skin warmth or redness
- Itching at application site
Serious — stop and see a doctor
- Increased risk of skin infections (bacterial, viral, or fungal)
- Herpes simplex (cold sore) reactivation in treated areas
- Potential long-term malignancy risk (black-box warning — use minimum necessary)
Important warnings
- Don't use Elidel Cream if you are allergic to pimecrolimus or any ingredient
- Not recommended in children under 2 years of age
- Minimise sun exposure during treatment and use sunscreen
Pimecrolimus brands in Pakistan (1)
Click any brand to see full uses, dosage, side effects, prices, and warnings.
Frequently asked questions
What is Pimecrolimus used for in Pakistan?
Pimecrolimus is commonly used for Mild to moderate atopic dermatitis (eczema), Short-term and intermittent long-term treatment of facial eczema, Steroid-sparing therapy in eczema-prone patients. It belongs to the calcineurin inhibitor / topical immunomodulator drug class.
What is the typical dosage of Pimecrolimus?
Typical adult dosing is described by manufacturers as: "Apply a thin layer twice daily to affected skin; use for the minimum necessary duration". Always confirm dose, duration, and timing with a qualified doctor or pharmacist — dose depends on indication, weight, age, kidney/liver function, and other medications.
What are the common side effects of Pimecrolimus?
Common side effects include Burning or stinging sensation at application site, Skin warmth or redness, Itching at application site. Most are mild and resolve as the body adjusts. Stop the medicine and contact a doctor if side effects are severe, persistent, or include allergic symptoms (rash, swelling, breathing difficulty).
When should I stop Pimecrolimus and see a doctor?
Stop Pimecrolimus and seek urgent medical care if you experience: Increased risk of skin infections (bacterial, viral, or fungal); Herpes simplex (cold sore) reactivation in treated areas; Potential long-term malignancy risk (black-box warning — use minimum necessary). These are serious signs that need immediate attention.
Is Pimecrolimus available without a prescription in Pakistan?
Prescription required.
What brands of Pimecrolimus are available in Pakistan?
1 brand of Pimecrolimus is listed on PakVita: 1 cream. Browse the brand list below and click any name for prices, dosage, and full information.
Sources
- DRAP Registered Drug Products Database — Drug Regulatory Authority of Pakistan
- British National Formulary (BNF) — BMJ Group & Pharmaceutical Press
- WHO Model List of Essential Medicines, 23rd ed. — World Health Organization